Julien Taieb
“Head, Gastroenterology & Digestive Oncology Department, Georges Pompidou European Hospital (AP-HP), Paris, France
Professor of Medicine, Université Paris Cité, France
Founder, AGEO (French Research Group on GI Tumours) | Faculty Coordinator, ESMO GI Colorectal Faculty”
Prof. Julien Taieb (MD, PhD) is Head of the Gastroenterology and Digestive Oncology Department at the Georges Pompidou European Hospital (AP-HP) and Professor of Medicine at Université Paris Cité, France. He is Founder of AGEO, the French research group dedicated to gastrointestinal tumours, and holds positions on the administrative councils of ESMO, FFCD, and SNFGE. He serves as Faculty Coordinator for the ESMO Gastrointestinal Tumours Colorectal Faculty and has been a member of the ESMO Nomination Committee since 2018. His main research areas are non-metastatic and metastatic colorectal cancer, pancreatic cancer, and the use of circulating tumour DNA (ctDNA) as a prognostic and predictive biomarker. He has led more than 10 national and international Phase II and III studies and over 20 Phase I/II studies, and has authored 3 educational books and more than 300 peer-reviewed publications, with over 42,000 citations. He is a regular reviewer for The Lancet Oncology, Journal of Clinical Oncology, Annals of Oncology, and the European Journal of Cancer.
Prof. Alessandra Gennari is Professor of Oncology at the University of Eastern Piedmont (UPO) and Head of the Division of Oncology at Maggiore University Hospital, Novara, Italy. She also leads the Laboratory of Immuno-Oncology at the UPO-CAAD Center for Immune and Allergic Diseases. Her expertise includes molecular and therapeutic innovation in breast cancer, with a focus on individual drug responsiveness, endocrine responsiveness imaging by PET-CT with 18F-FES, and immunotherapy in metastatic breast cancer. She has authored more than 100 peer-reviewed publications and is the first (lead) author of the ESMO Metastatic Breast Cancer (MBC) Guidelines.